Vaishali Pharma Q4 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
12.64
0.83 (7.03%)
0.83 (7.03%)Volume1.48 M
Updated: Tue 8 Jul, 2025 | 15:44:48
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹32.25 Cr.(-0.46%)
- Operating Profit₹-6.16 Cr.(-10.94%)
- Profit After Tax₹-4.29 Cr.(-8.33%)
- Operating Margin-19.12%(-10.53%)
Note: Comparison is on YoY basis
Quarterly - Vaishali Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 38.41 | 26.67 | 44.02% | 39.32 | -2.31% |
| Depreciation/ Amortization | 0.12 | 0.12 | 0.90% | 0.14 | -12.53% |
| Operating Income | -6.16 | 1.24 | 0.00% | -6.92 | -10.94% |
| Net Income | -4.29 | 1.44 | 0.00% | -4.68 | -8.33% |
| Other Operating Expenses Total | 6.90 | 2.18 | 216.31% | 6.23 | 10.79% |
| Net Income Before Taxes | -5.60 | 1.93 | 0.00% | -6.42 | -12.69% |
| Total Revenue | 32.25 | 27.91 | 15.52% | 32.40 | -0.46% |
| Selling/ General/ Admin Expenses Total | 0.74 | 0.63 | 17.27% | 0.63 | 17.11% |
| Diluted Normalized EPS | -3.17 | 0.98 | 0.00% | -0.44 | 623.93% |